Hedge Fund - Wildcat Capital Management

Allogene Therapeutics Inc. (ALLO) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $4,264,349 2.28% 2,920,787 $1.89
2 2024 - Q4 (2024-12-31) $6,221,276 2.46% 2,920,787 $2.47
3 2024 - Q3 (2024-09-30) $8,178,204 3.99% 2,920,787 $2.67
4 2024 - Q2 (2024-06-30) $6,805,434 1.66% 2,920,787 $2.95
5 2024 - Q1 (2024-03-31) $7,877,861 2.85% 1,920,787 $4.17
6 2023 - Q4 (2023-12-31) $6,165,726 2.13% 1,920,787 $2.84
7 2023 - Q3 (2023-09-30) $6,088,895 2.44% 1,920,787 $4.38
8 2023 - Q2 (2023-06-30) $9,546,311 3.63% 1,920,787 $5.41
9 2023 - Q1 (2023-03-31) $9,488,688 3.52% 1,920,787 $6.41
10 2022 - Q4 (2022-12-31) $13,387,447 5.11% 2,128,370 $9.26
11 2022 - Q3 (2022-09-30) $22,986,000 8.83% 2,128,370 $13.59
12 2022 - Q2 (2022-06-30) $24,263,000 8.03% 2,128,370 $8.88
13 2022 - Q1 (2022-03-31) $19,389,000 4.96% 2,128,370 $10.42
14 2021 - Q4 (2021-12-31) $25,608,000 4.17% 1,716,370 $17.64
15 2021 - Q3 (2021-09-30) $44,111,000 5.71% 1,716,370 $23.74
16 2021 - Q2 (2021-06-30) $44,763,000 5.07% 1,716,370 $28.52
17 2021 - Q1 (2021-03-31) $53,498,000 6.53% 1,515,524 $33.73
18 2020 - Q4 (2020-12-31) $38,252,000 4.8% 1,515,524 $32.59
19 2020 - Q3 (2020-09-30) $57,150,000 18.26% 1,515,524 $37.70
20 2020 - Q2 (2020-06-30) $64,895,000 22.41% 1,515,524 $36.17
21 2020 - Q1 (2020-03-31) $26,237,000 11.94% 1,349,642 $23.82
22 2019 - Q4 (2019-12-31) $31,223,000 9% 1,201,826 $27.54
23 2019 - Q3 (2019-09-30) $24,698,000 10.49% 906,194 $28.48
24 2019 - Q2 (2019-06-30) $14,289,000 6.18% 532,166 $27.86

The displayed share prices are average quarterly stock market prices.